ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Depreciation & Amortization (CF) of $9492.0 for Q1 2026, down 31.15% year-over-year from $13786.0 in Q1 2025, and down 6.18% quarter-over-quarter from $10117.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Depreciation & Amortization (CF) for 11 consecutive years, with $9492.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 31.15% year-over-year to $9492.0; the TTM figure through Mar 2026 stood at $39751.0 (down 11.62% YoY), while the FY2025 annual figure was $44045.0, down 5.26% from the prior year.
- Depreciation & Amortization (CF) declined to $9492.0 in Q1 2026 per NDRA's latest filing, from $10117.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $35265.0 in Q2 2023 and bottomed at $8693.0 in Q2 2024.
- Historically, Depreciation & Amortization (CF) has averaged $18847.8 across 5 years, with a median of $15300.0 in 2024.
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) soared 81.3% — and 2024, when it slumped 75.35%.
- ENDRA Life Sciences' Depreciation & Amortization (CF) stood at $32129.0 in 2022, then plunged by 31.88% to $21887.0 in 2023, then tumbled by 49.74% to $11000.0 in 2024, then declined by 8.03% to $10117.0 in 2025, then retreated by 6.18% to $9492.0 in 2026.
- Business Quant data shows NDRA's Depreciation & Amortization (CF) at $9492.0 in Q1 2026, $10117.0 in Q4 2025, and $10786.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 331.00 Mn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 196.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 41.05 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 67.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 292.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 14.52 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 51.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 13.30 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 146.00 Mn |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 9,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,492.00 |
| Mar 31, 2026 | 9,492.00 |
| Dec 31, 2025 | 10,117.00 |
| Dec 31, 2025 | 10,117.00 |
| Sep 30, 2025 | 10,786.00 |
| Sep 30, 2025 | 10,786.00 |
| Jun 30, 2025 | 9,356.00 |
| Jun 30, 2025 | 9,356.00 |
| Mar 31, 2025 | 13,786.00 |
| Mar 31, 2025 | 13,786.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,496.00 |
| Sep 30, 2024 | 11,496.00 |
| Jun 30, 2024 | 8,693.00 |
| Jun 30, 2024 | 8,693.00 |
| Mar 31, 2024 | 15,300.00 |
| Mar 31, 2024 | 15,300.00 |
| Dec 31, 2023 | 21,887.00 |
| Dec 31, 2023 | 21,887.00 |